These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22102490)

  • 21. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
    Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
    J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful management of a leiomyomatosis peritonealis disseminata with an aromatase inhibitor.
    Takeda T; Masuhara K; Kamiura S
    Obstet Gynecol; 2008 Aug; 112(2 Pt 2):491-3. PubMed ID: 18669776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of brain metastases from breast cancer that responded to anastrozole monotherapy.
    Ito K; Ito T; Okada T; Watanabe T; Gomi K; Kanai T; Mochizuki Y; Amano J
    Breast J; 2009; 15(4):435-7. PubMed ID: 19470131
    [No Abstract]   [Full Text] [Related]  

  • 24. Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report.
    Martin-Romano P; Jurado M; Idoate MA; Arbea L; Hernandez-Lizoain JL; Cano D; Paramo JA; Martin-Algarra S
    J Med Case Rep; 2017 Apr; 11(1):115. PubMed ID: 28424084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Possibilities to use the aromatase inhibitors for the treatment of the uterine fibroids].
    Persín J
    Ceska Gynekol; 2006 Mar; 71(2):146-9. PubMed ID: 16649417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of anastrazole on symptomatic uterine leiomyomata.
    Varelas FK; Papanicolaou AN; Vavatsi-Christaki N; Makedos GA; Vlassis GD
    Obstet Gynecol; 2007 Sep; 110(3):643-9. PubMed ID: 17766612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
    Stilwill SE; Cooper BC
    J Reprod Med; 2007 Oct; 52(10):979-80. PubMed ID: 17977182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole.
    Van Calster B; Van Ginderachter J; Vlasselaer J; Van de Putte G; Berteloot P; Timmerman D; Depypere H; Blomme C; Vlaemynck G; De Jonge E; Van den Broecke R; Vergote I; Amant F; Van Huffel S; Neven P
    Menopause; 2011 Feb; 18(2):224-9. PubMed ID: 20881891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.
    Murat Naki M; Tekcan C; Ozcan N; Cebi M
    Fertil Steril; 2010 Jun; 94(1):371-4. PubMed ID: 19896649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas.
    Vercellini P; Bocciolone L; Colombo A; Vendola N; Meschia M; Bolis G
    Acta Obstet Gynecol Scand; 1993 Jul; 72(5):369-73. PubMed ID: 8392268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists.
    Bedaiwy MA; Mousa NA; Casper RF
    Fertil Steril; 2009 Apr; 91(4 Suppl):1574-7. PubMed ID: 18973892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endometriosis and aromatase inhibitor].
    Takayama K; Bulun SE
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():157-60. PubMed ID: 11235156
    [No Abstract]   [Full Text] [Related]  

  • 33. Aromatase inhibitors in the treatment of early and advanced breast cancer.
    Joensuu H; Ejlertsen B; Lønning PE; Rutqvist LE
    Acta Oncol; 2005; 44(1):23-31. PubMed ID: 15848903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission of macroglobulinemia during anastrozole treatment for breast cancer.
    Chettle C; Baker MA
    N Engl J Med; 2005 Apr; 352(16):1725-6. PubMed ID: 15843681
    [No Abstract]   [Full Text] [Related]  

  • 35. Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial.
    Engman M; Granberg S; Williams AR; Meng CX; Lalitkumar PG; Gemzell-Danielsson K
    Hum Reprod; 2009 Aug; 24(8):1870-9. PubMed ID: 19389793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aromatase inhibitors: potential reproductive implications.
    Bedaiwy MA; Mousa NA; Casper RF
    J Minim Invasive Gynecol; 2009; 16(5):533-9. PubMed ID: 19608462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.
    Altman AD; Nelson GS; Chu P; Nation J; Ghatage P
    Int J Gynecol Cancer; 2012 Jul; 22(6):1006-12. PubMed ID: 22740004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Methods and efficacy of medical and surgical treatment of non functional menorrhagia].
    Brun JL; André G; Descat E; Creux H; Vigier J; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S368-83. PubMed ID: 19268216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letrozole.
    Dellapasqua S; Colleoni M
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):251-9. PubMed ID: 20095792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
    Boccardo F; Rubagotti A; Conti G; Potenzoni D; Manganelli A; Del Monaco D
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):415-20. PubMed ID: 15838655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.